Astellas Pharma Branches Out In U.S., Offers Career-building Workshops To Employees
This article was originally published in PharmAsia News
Executive Summary
With the national unemployment rate hitting 8.5 percent in March, the highest in 25 years, many U.S. pharmaceutical companies - once considered to have relatively strong cash reserves and traditionally immune to economic recessions - have begun slashing payrolls and announcing tens of thousands of layoffs